Vergoeding 2015-2019 voor ATC-subgroep J05AF : Nucleoside en nucleotide reverse-transcriptaseremmers

  • Raming voor de totale Zvw-populatie
  2015 2016 2017 2018 2019
J05AF01 Zidovudine (Retrovir ®) 54.545 46.755 43.341 32.785 19.823
J05AF02 Didanosine (Videx ®) 86.910 72.288 38.300 648 .
J05AF04 Stavudine 5.089 4.863 905 . .
J05AF05 Lamivudine (Epivir ®) 825.310 723.910 592.750 529.170 424.490
J05AF06 Abacavir (Ziagen ®) 644.640 653.630 585.930 505.680 385.090
J05AF07 Tenofovirdisoproxil (Viread ®) 6.926.200 6.949.800 6.492.100 2.534.500 990.430
J05AF08 Adefovir (Hepsera ®) 529.460 431.190 377.140 340.800 244.900
J05AF09 Emtricitabine (Emtriva ®) 98.819 111.560 80.060 57.383 50.456
J05AF10 Entecavir (Baraclude ®) 6.453.400 7.099.800 7.479.200 3.425.200 1.483.100
J05AF11 Telbivudine (Sebivo ®) 33.261 21.624 22.045 24.060 19.588
J05AF13 Tenofoviralafenamide (Vemlidy ®) . . 58.458 519.990 1.101.400
Totaal 15.657.634 16.115.420 15.770.229 7.970.216 4.719.277